Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127839271 | 12783927 | 1 | I | 2011 | 20160916 | 20160927 | 20160927 | EXP | IT-BAYER-2016-181567 | BAYER | RIBONI F; COSMA S; BENEDETTO C; PERINI PG. SUCCESSFUL PREGNANCY IN A PATIENT WITH ATYPICAL COGAN^S SYNDROME. ISRAEL MEDICAL ASSOCIATION JOURNAL. 2016;18 (8):495-496 | 33.00 | YR | A | F | Y | 0.00000 | 20160927 | MD | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127839271 | 12783927 | 1 | PS | ACETYLSALICYLIC ACID({=100 mg) | ASPIRIN | 1 | Oral | 100 MG/D, UNK | 21317 | ||||||||||
| 127839271 | 12783927 | 2 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | 300 MG, WEEKLY | 0 | 300 | MG | |||||||||
| 127839271 | 12783927 | 3 | SS | CYCLOSPORINE. | CYCLOSPORINE | 1 | 450 MG, WEEKLY | 0 | 450 | MG | |||||||||
| 127839271 | 12783927 | 4 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 200 MG, WEEKLY | 0 | 200 | MG | |||||||||
| 127839271 | 12783927 | 5 | SS | AZATHIOPRINE. | AZATHIOPRINE | 1 | 400 MG, WEEKLY | 0 | 400 | MG | |||||||||
| 127839271 | 12783927 | 6 | SS | PREDNISONE. | PREDNISONE | 1 | 15 MG, WEEKLY | 0 | 15 | MG | |||||||||
| 127839271 | 12783927 | 7 | SS | PREDNISONE. | PREDNISONE | 1 | 40 MG, QD | 0 | 40 | MG | QD | ||||||||
| 127839271 | 12783927 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | 20 MG, WEEKLY | 0 | 20 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127839271 | 12783927 | 1 | Cogan's syndrome |
| 127839271 | 12783927 | 2 | Cogan's syndrome |
| 127839271 | 12783927 | 3 | Cogan's syndrome |
| 127839271 | 12783927 | 4 | Cogan's syndrome |
| 127839271 | 12783927 | 5 | Cogan's syndrome |
| 127839271 | 12783927 | 6 | Cogan's syndrome |
| 127839271 | 12783927 | 7 | Cogan's syndrome |
| 127839271 | 12783927 | 8 | Cogan's syndrome |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127839271 | 12783927 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127839271 | 12783927 | Breech presentation | |
| 127839271 | 12783927 | Maternal exposure during pregnancy | |
| 127839271 | 12783927 | Off label use | |
| 127839271 | 12783927 | Placental necrosis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127839271 | 12783927 | 1 | 2007 | 0 | ||
| 127839271 | 12783927 | 2 | 2007 | 0 | ||
| 127839271 | 12783927 | 4 | 2009 | 0 |